View Older Stories

Mar 5, 2026 06:50AM Liquidia Corporation (LQDA) Misses Q4 EPS by 4c

Feb 17, 2026 10:39AM Liquidia Technologies (LQDA) Falls 14%

Jan 13, 2026 10:51AM Liquidia Technologies (LQDA) PT Raised to $55 at Jefferies

Jan 13, 2026 04:21AM BTIG Reiterates Buy Rating on Liquidia Technologies (LQDA)

Jan 9, 2026 10:52AM BTIG on Liquidia Technologies (LQDA): 'Next Important Catalyst Most Likely the '327 Trial Outcome'

Jan 9, 2026 06:30AM Liquidia Technologies (LQDA) Announces Preliminary Full-Year 2025 YUTREPIA Net Sales and Corporate Update

Jan 5, 2026 06:09AM Liquidia Technologies (LQDA) spreader of 2500 contracts of January 15 and 30 puts

Nov 4, 2025 04:48AM Liquidia Technologies (LQDA) PT Raised to $47 at Raymond James

Nov 3, 2025 03:52PM Liquidia Technologies (LQDA) PT Raised to $45 at Jefferies

Nov 3, 2025 02:22PM Liquidia Technologies (LQDA) PT Raised to $39 at BofA Securities

Nov 3, 2025 06:46AM Liquidia Corporation (LQDA) Tops Q3 EPS by 37c

Oct 16, 2025 06:16AM BofA Shuffles Endeavor List Names

Aug 15, 2025 07:43AM Jefferies Assumes Liquidia Technologies (LQDA) at Buy

Aug 13, 2025 05:48AM Liquidia Technologies (LQDA) PT Raised to $49 at BTIG

Aug 13, 2025 05:32AM Liquidia Technologies (LQDA) PT Raised to $41 at Raymond James

Aug 13, 2025 05:20AM Liquidia Technologies (LQDA) PT Raised to $31 at Wells Fargo

Aug 12, 2025 06:32AM Liquidia Corporation (LQDA) Misses Q2 EPS by 7c

Jun 23, 2025 04:34PM Liquidia Technologies (LQDA) Receives $50M from Healthcare Royalty (HCRx) Following First Commercial Sale of YUTREPIA

Jun 23, 2025 04:17AM Liquidia Technologies (LQDA) call put ratio 1 call to 1 put on 19K contracts

Jun 11, 2025 06:04AM Raymond James Reiterates Strong Buy Rating on Liquidia Technologies (LQDA)

Jun 2, 2025 01:38PM Raymond James on Liquidia Technologies (LQDA): 'we maintain our positive outlook for the simultaneous Yutrepia launches in PAH and PH-ILD'

Jun 2, 2025 01:00PM Liquidia Technologies (LQDA) PT Raised to $45 at BTIG, 'raising our probabilities of success for YUTREPIA in PAH and PH-ILD both to 99% from 95% '

Jun 2, 2025 07:06AM Liquidia Technologies (LQDA) PT Raised to $32 at Needham

Jun 2, 2025 06:31AM Liquidia Technologies (LQDA) Schedules First Commercial Shipment of YUTREPIA Inhalation Powder

Jun 2, 2025 04:56AM BTIG Reiterates Buy Rating on Liquidia Technologies (LQDA)

May 28, 2025 08:01AM Liquidia Technologies (LQDA) PT Raised to $33 at Raymond James

May 28, 2025 07:27AM Liquidia Technologies (LQDA) PT Raised to $35 at H.C. Wainwright

May 28, 2025 07:14AM Liquidia Technologies (LQDA) PT Raised to $37 at Scotiabank

May 28, 2025 05:24AM Liquidia Technologies (LQDA) PT Raised to $23 at Wells Fargo

May 27, 2025 03:42PM Liquidia Technologies (LQDA) PT Raised to $37 at BTIG

May 27, 2025 01:04PM Liquidia Technologies (LQDA) PT Raised to $31 at Jefferies

May 27, 2025 04:27AM Raymond James Reiterates Strong Buy Rating on Liquidia Technologies (LQDA)

May 27, 2025 04:20AM BTIG Reiterates Buy Rating on Liquidia Technologies (LQDA)

May 23, 2025 02:29PM Liquidia Technologies (LQDA): U.S. FDA Approves YUTREPIA Inhalation Powder for Patients with PAH and PH-ILD

May 23, 2025 02:01PM Liquidia Technologies (LQDA) Halted, News Pending

May 21, 2025 12:42PM Scotiabank Reiterates Sector Outperform Rating on Liquidia Technologies (LQDA)

May 21, 2025 07:08AM Needham Reiterates Buy Rating on Liquidia Technologies (LQDA), PT $25

May 21, 2025 06:13AM Raymond James Reiterates Strong Buy Rating on Liquidia Technologies (LQDA)

May 21, 2025 05:13AM BTIG Reiterates Buy Rating on Liquidia Technologies (LQDA)

May 19, 2025 08:14AM Oppenheimer Downgrades Liquidia Technologies (LQDA) to Underperform

May 12, 2025 01:36PM Raymond James on Liquidia (LQDA): 'we see this narrower repackaging of the '793 patent as posing a relatively low risk of becoming a basis for RTO or injunction of the Yutrepia launch'

May 8, 2025 06:58AM Liquidia Corporation (LQDA) Misses Q1 EPS by 5c

May 5, 2025 06:52AM Liquidia Technologies (LQDA) PT Raised to $36 at Scotiabank

Mar 28, 2025 09:31AM Liquidia Technologies (LQDA) Announces FDA Acceptance of New Drug Application Resubmission for YUTREPIA (treprostinil) Inhalation Powder

Mar 20, 2025 07:25AM Liquidia Technologies (LQDA) PT Raised to $34 at Scotiabank

Mar 20, 2025 06:40AM H.C. Wainwright Reiterates Buy Rating on Liquidia Technologies (LQDA)

Mar 20, 2025 06:19AM Raymond James Reiterates Strong Buy Rating on Liquidia Technologies (LQDA)

Feb 24, 2025 07:04AM Atea Pharmaceuticals Inc. (AVIR) Appoints Arthur S. Kirsch to its Board

Oct 8, 2024 06:14AM Raymond James Reiterates Strong Buy Rating on Liquidia Technologies (LQDA)

Oct 8, 2024 06:09AM LifeSci Capital Reiterates Outperform Rating on Liquidia Technologies (LQDA)

View Older Stories